Mastering GLP-1 Agonists

Want CE credit and access to this content? Join the Pinnacle Continuing Education Membership to gain access to exclusive digital content including webinars, live events, book clubs, and more. Earn CE credit while consuming content you enjoy from creators you already love. 

In “Mastering GLP-1 Agonists,” Dr. Alexandra Sowa, a board-certified internist and obesity medicine specialist, provides an in-depth exploration of GLP-1 receptor agonists as a therapeutic tool in the management of obesity and Type 2 diabetes. Through this recorded Q&A, Dr. Sowa answers practical questions about GLP-1 mechanisms of action, patient eligibility, dosing strategies, and management of common side effects. She also highlights evidence-based outcomes for weight loss and metabolic health improvements. This engaging session is designed to clarify misconceptions and address real-world challenges, empowering healthcare professionals to optimize treatment outcomes for their patients.

More about Dr. Alexandra Sowa
Dr. Alexandra Sowa is a board-certified physician of Internal Medicine, specializing in preventive health, nutrition and obesity medicine. She is a diplomate of the American Board of Obesity Medicine. After graduating with honors from Johns Hopkins University, Dr. Sowa attended New York University School of Medicine, where she completed both medical school and a residency in Internal Medicine. Alexandra currently practices in New York City and holds an appointment as Clinical Instructor in Medicine at New York University School of Medicine. She is honored to have been named 1 of 4 ‘Rising Star’ Super Doctors in New York City for Internal Medicine in 2017, 2018 and 2019. She has also served as an on-air health expert for national media outlets like Fox News, CBS News, NPR and Inside Edition. Her medical opinions have been featured in various print publications, from the New York Times to U.S. News and World Report to Glamour and Parents Magazine.